Phibro Animal Health (PAHC) Scheduled to Post Earnings on Wednesday

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, November 6th. Analysts expect the company to announce earnings of $0.23 per share for the quarter. Phibro Animal Health has set its FY 2025 guidance at 1.220-1.370 EPS.Persons interested in registering for the company's earnings conference call can do so using this link.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.34 by $0.07. The company had revenue of $273.16 million during the quarter, compared to the consensus estimate of $262.44 million. Phibro Animal Health had a return on equity of 18.08% and a net margin of 0.24%. On average, analysts expect Phibro Animal Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC traded up $0.20 during mid-day trading on Wednesday, reaching $23.70. The company had a trading volume of 159,761 shares, compared to its average volume of 154,950. Phibro Animal Health has a 1-year low of $9.40 and a 1-year high of $25.11. The stock has a market cap of $959.85 million, a PE ratio of 391.73, a P/E/G ratio of 0.58 and a beta of 0.52. The company has a current ratio of 2.94, a quick ratio of 1.64 and a debt-to-equity ratio of 1.79. The company has a 50-day moving average price of $21.94 and a two-hundred day moving average price of $18.86.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on PAHC shares. JPMorgan Chase & Co. assumed coverage on Phibro Animal Health in a report on Tuesday, September 10th. They set a "neutral" rating and a $22.00 price objective on the stock. Bank of America upped their price target on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an "underperform" rating in a research report on Friday, August 30th. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $15.00.

Insider Buying and Selling at Phibro Animal Health

In related news, Director E Thomas Corcoran bought 5,000 shares of Phibro Animal Health stock in a transaction that occurred on Wednesday, September 4th. The stock was purchased at an average cost of $20.02 per share, for a total transaction of $100,100.00. Following the acquisition, the director now owns 25,000 shares in the company, valued at $500,500. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 50.07% of the company's stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.